Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on January 14, 2008

Hypertension. 2008
Published online before print January 14, 2008, doi: 10.1161/HYPERTENSIONAHA.107.103176
A more recent version of this article appeared on February 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
51/2/547    most recent
HYPERTENSIONAHA.107.103176v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verlohren, S.
Right arrow Articles by Dechend, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verlohren, S.
Right arrow Articles by Dechend, R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Risk Pregnancy
Hazardous Substances DB
*PHENYLEPHRINE
Related Collections
Right arrow Remodeling
Right arrow Animal models of human disease
Right arrow Other hypertension
Right arrow Hypertension - basic studies
Right arrow Peripheral vascular disease

Submitted on October 12, 2007
Revised on November 6, 2007

Uterine Vascular Function in a Transgenic Preeclampsia Rat Model

Stefan Verlohren; Manuela Niehoff; Lydia Hering; Nele Geusens; Florian Herse; Andrei N. Tintu; Andreas Plagemann; Ferdinand LeNoble; Robert Pijnenborg; Dominik N. Muller; Friedrich C. Luft; Joachim W. Dudenhausen; Maik Gollasch; and Ralf Dechend*

From the Departments of Obstetrics (S.V., M.N., A.P., J.W.D.), and Nephrology (M.G.), and Department of Cardiology, Franz Volhard Clinic, HELIOS Klinikum Berlin-Buch (F.H., R.D.), Charité University Medicine, Berlin, Germany; Experimental and Clinical Research Center (F.C.L.), Max Delbrueck Center for Molecular Medicine (S.V., L.H., A.N.T., F.L., D.N.M., F.C.L.), Berlin, Germany; and the Department of Gynecology and Obstetrics (N.G., R.P.), University of Leuven, Leuven, Belgium.

* To whom correspondence should be addressed. E-mail: ralf.dechend{at}charite.de.

Abstract—We investigated intrauterine growth restriction, endothelial function, and uterine artery blood flow characteristics in a transgenic preeclampsia rat model with an activated renin-angiotensin system. We compared preeclamptic Sprague-Dawley (SD-PE) rats with normal pregnant Sprague-Dawley and nonpregnant Sprague-Dawley rats. We used transabdominal ultrasound and found that SD-PE rat embryos developed intrauterine growth restriction. Isolated uterine arteries from SD-PE rats incubated with phenylephrine exhibited an increased contractile response, whereas a single high dose of acetylcholine resulted in an impaired vasorelaxation compared with controls. Incremental acetylcholine doses increased relaxation of SD-PE vessels at low acetylcholine doses but caused a paradoxical contraction at higher acetylcholine doses. Indomethacin and a thromboxane-receptor antagonist (SQ 29,548) blocked this effect, suggesting maternal prostanoid-dependent endothelial dysfunction. SD-PE rats had a decreased prostacyclin (6-keto-prostaglandin F1{alpha}):thromboxane ratio in the serum compared with normal pregnant Sprague-Dawley rats or nonpregnant Sprague-Dawley. Surprisingly, the Doppler resistance index decreased during pregnancy in SD-PE compared with normal pregnant Sprague-Dawley rats, suggesting unimpaired uteroplacental flow in the uterine artery. Umbilical flow was unchanged with absent end-diastolic flow in all of the groups. Renin-angiotensin system activation–induced preeclampsia is associated with altered placentation, modified resistance index, and endothelial dysfunction. A disturbed prostacyclin:thromboxane ratio could be an important mediator.


Key words: preeclampsia • uterine artery • rat • endothelial dysfunction • intrauterine growth restriction • Doppler ultrasound




This article has been cited by other articles:


Home page
HypertensionHome page
S. Verlohren, D. N. Muller, F. C. Luft, and R. Dechend
Immunology in Hypertension, Preeclampsia, and Target-Organ Damage
Hypertension, September 1, 2009; 54(3): 439 - 443.
[Full Text] [PDF]


Home page
PhysiologyHome page
G. Osol and M. Mandala
Maternal Uterine Vascular Remodeling During Pregnancy
Physiology, February 1, 2009; 24(1): 58 - 71.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. Herse, S. Verlohren, K. Wenzel, J. Pape, D. N. Muller, S. Modrow, G. Wallukat, F. C. Luft, C. W.G. Redman, and R. Dechend
Prevalence of Agonistic Autoantibodies Against the Angiotensin II Type 1 Receptor and Soluble fms-Like Tyrosine Kinase 1 in a Gestational Age-Matched Case Study
Hypertension, February 1, 2009; 53(2): 393 - 398.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
W. Chen and R. A. Khalil
Differential [Ca2+]i signaling of vasoconstriction in mesenteric microvessels of normal and reduced uterine perfusion pregnant rats
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1962 - R1972.
[Abstract] [Full Text] [PDF]